KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Shares Issued (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Shares Issued for 16 consecutive years, with $34.9 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 166.85% to $34.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.9 million through Dec 2025, down 3.12% year-over-year, with the annual reading at $34.9 million for FY2025, 3.12% down from the prior year.
  • Shares Issued hit $34.9 million in Q4 2025 for Inovio Pharmaceuticals, up from -$1.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $162.1 million in Q1 2021 to a low of -$29.2 million in Q2 2022.
  • Historically, Shares Issued has averaged $20.0 million across 5 years, with a median of $4.1 million in 2023.
  • Biggest five-year swings in Shares Issued: crashed 3217.84% in 2023 and later skyrocketed 885.0% in 2024.
  • Year by year, Shares Issued stood at $47.3 million in 2021, then crashed by 99.8% to $93500.0 in 2022, then plummeted by 3217.84% to -$2.9 million in 2023, then skyrocketed by 548.74% to $13.1 million in 2024, then skyrocketed by 166.85% to $34.9 million in 2025.
  • Business Quant data shows Shares Issued for INO at $34.9 million in Q4 2025, -$1.1 million in Q2 2025, and $1.1 million in Q1 2025.